Filters
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Epilepsy Comprehensive NGS Panel Fulgent Genetics United States | 729 | 398 |
|
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3 Bioarray Spain | 1 | 1 |
|
CeGaT GmbH Germany | 2 | 15 |
|
Fulgent Genetics United States | 3 | 1 |
|
Syndromic Congenital Muscular Dystrophy NGS Panel Fulgent Genetics United States | 14 | 5 |
|
Dystroglycan-Related Congenital Muscular Dystrophy NGS Panel Fulgent Genetics United States | 67 | 13 |
|
Fulgent Genetics United States | 5129 | 4672 |
|
Fulgent Genetics United States | 259 | 112 |
|
Intellectual Disability NGS Panel Fulgent Genetics United States | 1058 | 554 |
|
Fulgent Genetics United States | 31 | 14 |
|
Muscular dystrophy / dystroglycanopathy A3 MedGene Slovakia | 1 | 1 |
|
Comprehensive Eye Disorders NGS Panel Fulgent Genetics United States | 1018 | 459 |
|
Muscular Dystrophies NGS Panel Fulgent Genetics United States | 125 | 42 |
|
Muscular dystrophy / dystroglycanopathy A3 Praxis fuer Humangenetik Wien Austria | 1 | 1 |
|
Test for POMGNT1-Related Muscle Diseases Genome Diagnostics Laboratory Hospital For Sick Children Canada | 1 | 1 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.